Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 102,666 m |
| EPS, EUR | - |
| P/B ratio | 1.4 |
| P/E ratio | 12.2 |
| Dividend yield | 3.27% |
| Revenue, EUR | 41,081 m |
| Net income, EUR | 5,496 m |
| Profit margin | 13.38% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.18% | Equity United States Health Care Biotech | 43 |
| YTD | -11.13% |
| 1 month | -7.57% |
| 3 months | +3.23% |
| 6 months | -5.68% |
| 1 year | -7.57% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | -4.82% |
| 2024 | +4.01% |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| Volatility 1 year | 27.01% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.28 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -29.45% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -29.45% |